Charity reglstrallon number NIC101345
Company reglstration number N1616925 (Northèrn lrnland)
FRIENDS OF THE CANCER CENTRE
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

FRIENDS OF THE CANCER CENTRE
LEGALAND ADMINISTRATIVE INFORMATION
Patrons
Mr John Daly
Mr Eamonn Holmes
Mr lain Henderson
Mr Denis Moloney
Directors
Mr B Cavè
Ms C Aiken
Dr D Flnnegan
Prof S Jain
Mr R Donnan
Ms C Keenan
Dr S McAleer
ProfAAdair
Mr P Mcmaw
Mr J Rlce
Prof M Durkln
Mr Brlan Fee
Mr D Cubbitt
Dr Caroline Ford8
(Appolnted 9 June 2023)
(Appointed 9 June 2023)
(Appointed 15 September 2023)
(Appolnted 23 F8bruary 20241
Secratary
Ms C Keenan
Charity number
NIC101345
Company number
N1616925
Reglstered office
N.1. Cancer Centre
Belfast Cily Hospiial
Lisbum Road
Belfast
Co. Anlrim
BT9 7AB
Auditor
Harblnson Mulholland
C8ntrepoint
24 Omieau Avenue
Belfast
Co. Antrim
Northern Ireland
BT2 8HS
Bankers
Ulster Bank Llmited
11-16 Donegall Square East
Belfast
BT15UB

FRIENDS OF THE CANCER CENTRE
CONTENTS
Page
Dlr8Ctors' report
Stat8ment of Dlrectors, rasponsibilltles
Independent auditorfs report
ststement of financlal actlvlties
10
Statement of flnanclal position
Statement of cash flows
13
Notes to the financlal statements
14-24

FRIENDS OF THE CANCER CENTRE
DIRECTORS. REPORT (INCLUDING DIRECTORS. REPORT)
FOR THE YEAR ENDED 31 MARCH 2024
The Directors present their annual report and financial staternents for the year ended 31 March 2024.
The financial statements have been prepared in accordance with the accounting policies sel out in note 1 to the
rinancial slaternents and comply with the Companies Act 2006 and "Accounting and Reporting by Charities:
Statement of Recommended Practice appllcable to charities preparing their accounts in accordance with the
Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021" las amended for
accountlng periods commencing from 1 January 20161
Objectlves and actlvitles
The Charity operates in Northern Ireland and Its objectives are to support patients and their familiès by
enhancing the quality of care they rèceive and contribute to can￿r care. treatment and research throughout
Northern Ireland.
Achlevament8 and performance
During the year funds amounting to £1,165,205 were used to contrlbute to research, patient comfort, Clinical care
and ¢ampaigns throughout Northern Ireland. These break down as follows..
Research
Radiotherapy Physics Support Position 76%
Radiotherapy, Research & Development Radiographer
Patrick G. Johnston Centre for Cancer Research, N.1. Cancer Centre Trials Grant
17,233
64,180
342,058
423,471
Patlent Comfort
Teenaga & Young Adults Group Programme
North West Cancer Cent￿, Coffee Dock Supplies
Social Work Granls, Nl Cancer Centre
Drinks Machines, Nl Cancer Centre
Support for Breast Health & W811 Belng Events
Physiotherapy, Physical Activity Cancer Referral Coach
Radiotherapy, Clothing for Patlents
Social Work Grants, North West Cancer Centre
Bridgewater Suite, Refreshments for Patients
Macmillan Support & Informatlon Centre, Support & Wellbeing Programffle
Radiotherapy, Refreshments for Patient Coffee Dock
Radiotherapy, Children's Activity Gifts
Garden Materials, Nl Can￿r Centre and Macmillan Support & Infomation Centre
Ward 10 North Refurbishment of Dayroom
AOHU Dayroom Refurbishment of Chairs
Christmas Presents for Patients and Hampers for Staff
Teenage & Young Adults, Christmas Vouchers Regional
Support for Prostate Cancer Health & Wellbeing
TV for Ward 2A Dayroorn
3,524
1,081
115,950
3,252
479
35,567
131
11,300
12,000
113,093
2,465
495
774
4,206
1,810
1,334
1,225
728
485
309,899

FRIENDS OF THE CANCER CENTRE
DIRECTORS. REPORT (INCLUDING DIRECTORS. REPORT) (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
Patlent Care
North West Cancer Centre. Upper Gl Support Worker
North West Cancer Centre, Upper Gl. Clinical Nurse Specialist
North West Cancer Centre, Research & Development Radiographer
Clinical Nurse Specialist, Secondary Breast Cancer Nurse
Speech & Language Therapy Assistant Manager
Library Books, Nl Cancer Centre
Radiotherapy, Physics Support Posltlon 25D
Occupatlonal Therapy, Pressure Reduclng Cushions
Dletitian Clinical Specialist, Nl Cancer Centre
Radiotherapy, Thumbs Up
Antrim Area Hospital, Clinical Nurse Specialist, Head and Neck
Nl Cancer Centre, Leukaemia Clinical Nurse Specialist, Haematology
Gynae Oncology Clinical Nurse Speclallsl, Gynaecology Surgery, Belfast City Hospital
O¢cupational Therapy, Pressure Reducing Cushions Gynae & Rectal Patients
Teenage & Young Aduh Social Worker, Nl Can¢8r Centre
Clinical Nurse Speclallst Programme
Clinical Nurse Specialist, Teenage & Young Adults
Cllnlcal Nurse Specl811sl. Teenage & Young Adults
Scholarship, Pamela Lutton
Scholarshlp, Pearl Ewing
Scholarship, Dr Gary McGowan
Tralning x 2, QA Praclilioner & Cllnical Nurse Specialist, Head & Néck
3.549
20,852
22.245
40,724
22,487
996
5,144
1,693
32,325
150
32,562
37,259
22,457
1,362
26,196
66,828
31,898
31,935
2,000
1,989
2,000
1,000
407,651
Cam
al
Campalgns
24,184
24,184
1,165,205

FRIENDS OF THE CANCER CENTRE
DIRECTORS. REPORT (INCLUDING DIRECTORS. REPORT) (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
Financial rovlew
The net movement of funds amounted to incoming of £153,364, of which £172,608 incoming related to
unrestricted actlvltles and £19,244 outgoing related to restrldéd funds. The Charity is involved in various fund-
raising activities to provide adequate resources to meet ils objectives. The Directors are very pleased with the
total income generated of £1,677,544 in the year in relation to the £127.384 expended on fundralsing and
£66,374 on admlnlstratÉon.
At 31 March 2024 the Charity had unrestricted reseNes of £3,524,246 of which £3,470,503 has b66n committed
to support continuing activltles within thè Cancer Centre. The free uncommitted balan￿ of funds is £53,743.
Re8ervès poll¢y
The Directors. Informed by the risk reglster. op8ratlng budget and known commitm8nts and Ilabllllles, have
established a pollcy for the general reserves held by the Charoly. The organisatlon is entirely dependent upon
Iluctualing donor funding from year to year, and it requires protection against and th8 ability to continue despite, a
d¢)wntum in income.
General ReseNe: the directors bellevè that the mlnlmum level of general r8seNes should be the
equivalent of six months, operating costs and six months. commitments calculated and reviewed
annually and believe that the réserves should be built up to the desired lev81 in stages conslslent with
the Charity's overall financlal position and its need lo maintain and develop its charitabl8 actlvlll8S.
Designated Reserves.. To enabl8 the Charity lo support projects and research posts whlch cover more
than on8 year the directors designate those funds for which grants have been commltted or approved
for a period of up to 2 years from the period end. The dlrectors are of the oplnion that approximately
£950.000 of deslgnated funds would fall due for payment In the 6 months from the balance sheet date.

FRIENDS OF THE CANCER CENTRE
DIRECTORS. REPORT (INCLUDING DIRECTORS. REPORT) (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
structure, governanco and management
The Charity Is a company limited by guarantee and does not have a shara capital. It is governed by a
Mèmorandum and Articles of Association and the liability of each member is limited to an amount not exceeding
£1.
The directors must offer their resignation after hvo years bul can make themselves available for re-election In
accordance with the Articlés of Associalion. There werè 15 directors serving during the period up 10 31 March
2024.
New Dlrectors are appolnted by the Board. The aim of the recruitment proc8ss Is to appolnt th8 most suitable
person for the position of Director. Recruitment of new Directors will take into account the Charity's need for new
ideas and fresh 8pproa¢hes. Th& last skills audit was Carrled out in 2024 and Is periodically revlewed by the
Board.
The Dlr8Ctors who served durlng the year and up to the date of slgnature of the flnancial statements w8r8:
Mr B Cave
Dr P Scullin
Ms C Aiken
Dr D Finnegan
Prof S Jain
Mr R Donnan
Ms C Keenan
Dr S McAleer
ProfAAdalr
Mr P Mcmaw
Mr J Rice
Prof M Durkin
Mr Brian Fee
Mr D Cubbitt
Dr Caroline Forde
(Reslgned 24 Novemb8r 2023)
(Appointed 9 June 20231
(Appointed g June 20231
{Appointed 15 September 2023)
(Appointed 23 February 2024)
Audltor
Harbinson Mulholland have indicated thelr wlllingness to contlnue in office.
D18closuro 01 informatlon to audltor
Each of the Oirectors has confirmed that Ihere is no Informatlon of which ihey are aware whlch Is relevant to the
audit. but of which the auditor is unaware. They have further confirmed that they have taken approprlate steps to
Identify su¢h r81evant information and to 8slabllsh that the auditor is aware of suGh information,
Thls report has been pr8pared in accordance wlth sp8clal provision of Part 15 of the Companles Act 2006
relating to small companies.
The Directors, report was approved by the Board of Directors.
Caroline Keenan INOV 19, 2024 14..07 GMT)
Ms C Keenan
Director
Dated.. 22 November 2024

FRIENDS OF THE CANCER CENTRE
STATEMENT OF DIRECTORS. RESPONSIBILITIES
FOR THE YEAR ENDED 31 MARCH 2024
Thè directors. who also act as tTUStees, are responslble for preparing the Directors, Report and the financial
statements in accordance with applicable law and regulation.
Company law requires the Directors to prepare financial statements for each financi81 year. Under that law the
Directors have PrePa￿d the financial slalements in accordance wrth United Klngdom Accounting Standards,
comprising FRS 102 "Thè Financial Reporting Standard applicable in the UK and Republic of Ireland", and
applicable law (United Kingdom Generally Accepted Accounting Practice}. Under company law the Directors must
not approve the financial statements unless thèy are satisfied that they give a true and fair view of the stste of the
affairs of the and of the incoming resources and application of resources, including the incom8 and expenditure, of
the for thal period. In preparing th8se ffinan¢ial statements. the Directors are required to;
select suitable accounting policies and then apply them consislently;
observe the methods and principles in the Statement of Recommended Practl¢e.' Accounting and R8POrtlng
by Charilles {2015)',
make judgménts and estlmales that are reasonable and prudent,. and
prepare the financi81 statements on the going con￿rn basis unless It Is Inapproprlate to presume that the
will continue in business.
The Dlrectors are responsible for keeplng adequate accounting records that are suffici8nt to show and explain the
company's transactions and disdose wllh reasonable accuracy at any tlme the financial position of the company
and enable them to ensure that the company comply with the Companies Act 2006. They are also responsible for
safeguarding the assets of the company and hence for taking reasonable steps for the p￿VentIon and detection of
fraud and other irregularities.
In certain circumstances clients may choose to include an additional staternent here which is requlred to be made
within thè direclors, report as a result of Sectron 418 of the Companies Act 2006.
In accordance with Section 418, directors, reports shall include a stat8m8nt, in the case of each director in offic8 at
the date the directors, report is approved, that:
(a) so far as the trustee is aware, there is no relevant audit informatlon of which the company's auditors are
unaware., and
(bl they have taken all the steps that they ought to have taken as a trustee In order to make themselves aware of
any relevant audit information and to establish that the Company's auditors are aware of that informatlon.
By order of the Board of Directors
ol lié Eegha
Caroline Keenan (Nov 19, 2024 14:07 GMTI
Ms C Keenan
Dlreclor
22 November 2024

FRIENDS OF THE CANCER CENTRE
INDEPENDENT AUDITOR'S REPORT
TO THE DIRECTORS OF FRIENDS OF THE CANCER CENTRE
Oplnlon
We have audited the financial statements of Frionds of the Cancer Centr8 Ilhe 'Charity') for the year ended 31
March 2024 which comprise the statement of financial activities, the statement of financial position. the slalemenl of
cash flows and the notes lo the financial statements. including significant accounting policies. The financial reporting
framework that has been appliad In their preparation is applicable law and United Kingdom Accounting Standards,
including FRS 102 The Financi81 Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom
Generally Accepted Accounting Practice).
In our opinion, the financial statements:
give a true and fair view of the statè of the charitable company's affairs as at 31 March 2024 and of its
incomlng resources and application of resources, for the year then ended;
have been properly prepared in accordance with United Kingdom Gènerally Accepted Accounting Practice"
and
havè been prepared in accordance with the requirèments of the Companies Act 2006.
Basls for oplnion
We conducted our audit In accordance with International Standards on Auditing (UK) IISAS (UK)) and applicable
law. Our responsibllllies under those standards are further described In the Auditorfs responsibilitles for the audit of
the financial stalements section of our report. We are Indep8ndent of the Charity In accordance wlth the ethical
requirèments that 8re r8levant to our audit of the flnancial statements In the UK, including the FRC'S Ethical
Standard. and we have fulfilled our other ethical responsibiliti8s in accordance with these requirements. We believe
that the audit evidence we have obtained is sufficient and appropriate lo provide a basis for our opinion.
Concluslons relatlng to going concern
We have nothing to report In respect of the following matters in relation to whlch the ISA5 (UK) require us to report
lo you were..
the directors, use of the golng concem basls of accounting in the preparation of the financlal stslements 1$
not appropriate; or
the directors have not disclosed in the financial statements any identified material uncertainties thal may
cast significant doubt about thè group's or the parent company's abillty to continue to adopt the going
ncem basis of accounting for a period of at least ￿e1ve months from the date when the financial
statements are authorised for issue.
Other infomiatlon
The other information ￿mPriseS the information included in the Directors, Report, other than the finan¢lal
statements and our auditor's report thereon. The directors are responslble for the other information. Our opinion on
the financlal statements does r￿t cover the other information and. except to the extent otherwis8 explicitly stated in
our report, we do not express any form of assuran￿ conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the olher infomation and. in
doing so, consider whether the other infomiation is materially inconsistent with the financlal statements or our
knowledge obtained in the audit or othe￿iSe appears to ba materially misstated. If we identify such material
inconsistencies or apparent material misstatements, we are required to determine whether there is a material
misstatement in the financial statements or a material misstatement of the other information. If, based on the work
we have performed, we conclude thal there is a materlal misstatement of this other infomiation, we are requlred to
report that fact.
We have nothing to report in this regard.

FRIENDS OF THE CANCER CENTRE
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE DIRECTORS OF FRIENDS OF THE CANCER CENTRE
Oplnlons on other matters prescribed by the Companies Act 2006
In our opinion, baséd on the work undertaken in the course of our audit:
thè information given in the Directors, report, which includes thè directors, report prepared for the purposes of
company law, for the financial year for which the financial statements are prepared is conslstant wlth the
financial statèmgnts., and
the directors, report included withln the Directors, report has been prepared in accordance with applicabl8
legal requirernents.
Matters on whlch w• ar• required to rnport by •xeèption
In the light of the knowledg6 and understanding of the Charllable company and Its envlronment obtained in the
cours8 of the audit, we hav8 not identlfied material misstatements In the Strategic Report and Ihe Dlredors, Report.
We have nothing to report In respect of the followlng matters in relation to which th8 Charitles (Accounts and
Reports) Regulatlons 2008 require us to report to you if, in our opinion-
adequate aGcounting records hava not been kept or returns adequate for our audit have not been recelv8d
from branches not visited by us., or
the financlal statements are not In agreement with the accountlng record5 and ￿turns,. or
certain disclosures of trustees, remuneration speclfied by law are not made., or
we have not received all the informatlon and explanations we require for our audlt.
Responsibllltles of Dlrectors
As exp18ined more fully in the statement of Directors, responsibilities, the Directors are responsible for the
preparation of the financial statements and for being satisfied that they give 8 true and fair vièw, and for such
internal control as the Directors determine Is necassary to enable the preparatlon of financi81 statements that are
free from fflaterlal rnisslatement, whether due lo fraud or error.
In prep8rlng the financial statements, the Directors are rosponsible for assessing the Charity's abilty to conllnue as
a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of
accounting unless the Directors either intend to liquidate the charitable company or to cease operations, or have no
realistic alternative but to do so.
Audttorfs responslbilitlbs for the audlt of the flnanclal statsments
Our objectives are to obtaln r8asonabl8 assurance about whether the flnanclal Statements as a whole are fre8 from
material misstat8ment, whether due to fraud or error, and lo issue an auditor's report that includes our opinion.
Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance
with ISAS (UK) will always dètect a material misslatemenl when it exists. Misstatomenls can arise from fraud or
error and are considered materlal If, individually or in the aggre9ate, they could reasonably be 8xpecled to influence
the economic decisions of users taken on the basls of these financial statements.
A further des¢rlpiion of our responslbllities Is available on the Financlal Reporting Council's w8bslle at.. httPS:/I
www.frc.org.ukjauditorsresponsibilities. This description forms part of our auditols report.

FRIENDS OF THE CANCER CENTRE
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE DIRECTORS OF FRIENDS OF THE CANCER CENTRE
Our approach to identifying and assessing the risks of material misststement in respect of irregularitles, including
fraud and non-compliance wlth laws and regulations, was as follows..
the engagement partner ensured that the engagement team collectively had the approprlale competence,
capabilities and skills lo identify or recognise non-compliance with applicable laws and regulations,.
we identlfied the laws and regulations applicable lo the company through discussions with directors andlor
senior management, and from our commercial knowledge and experience of the s6ctor:
We focused on specific laws and regulations which we considered may have a dlrect material Èffect on the financial
statements or the operatlons of the company, Including Companles Act 2006, taxation legislation, data protection,
anti-bribery, employment, environmental and health and safety legislation
we assessed th8 extent of Compliance with the laws and regulations Identifi8d above through maklng
enquiries of management and inspectlng legal wrrespondence; and
Identified laws and regulallons were communicated withln the audit team regularly and the team remalned
alert to instances of non-compliance throughout the audit.
We assessed the susceptibllity of the company's financial 5tatem8nls to material mlsslatement, includlng obtalning
an understanding of how fraud might occur, by..
making enquiries of management as to where they conSide￿d there was susceptiblllty to fraud. their
knowledge of actual, suspected and alleged fraud,. and
considering the Internal controls in place to mitigate risks of fraud and non<ompliance with laws and
regulations.,
To address the risk of fraud through management bias and overrlde of controls, we:
performed analytical procedures to Identity any unusual or unexpected relationships.
tested journal entries to idenlify unusual transactions.,
assessed whether judgements and assumptions mad8 In determining the accountlng estimates set out in
Note 2 were Indicative of poienlial bias., and
investigated the rattonale behind significant or unusual transactlons.,
In response to the risk of Irregularitie5 and non-compliance with laws and regulation8, we designed procedures
which included, but were not limiled to:
agreeing financial slalement disclosures to underlying supportlng documentation;
reading the minutes of meetings of those charged with govemance-
enquiring of managemenl as to actual and potential litigation and claims,. and
reviewing Correspondence with HMRC and the company's legal advisors.,
There are Inherent Ilmilalions in our audit procedures described above. The more removed that laws and
regulations are from financial transaction5. the less likely il is that we would become aware of non-compliance.
Auditing standards also limit the audrt proCedU￿S required to identify non<ompliance with laws and regulations to
enqulry of the dire¢lors and other management and the inspection of regulatory and legal correspondence, if any.
Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may
involve deliberate concealment or collusion.

FRIENDS OF THE CANCER CENTRE
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE DIRECTORS OF FRIENDS OF THE CANCER CENTRE
This report is made solely to thè charitsble company's members, as a body, in accordance with Chapter 3 of Part 16
of the Companies Act 2006. Our audlt work has been undertaken so that we might stste to the parent charitable
company's members those matters we are required to state to them in an audltols réport and for no other purpose.
To the fvllesl extent permltted by law. we do not accept or assume responsibility to anyone other than the company
and the charitable company's members as a body, for our audit work, for this report, or for the oplnions we have
fonned.
fciA
Angela Craigan Isenlor Statutory Audltor)
for and on behalf of Harblnson Mulholland
Chartered Accountants
Statutory Audltor
Centrepoint
24 Omieau Avenue
Belfast
Co. Antrlm
BT2 8HS
2211112024
Harblnson Mulholland is eligible for appointment as auditor of the Charity by vlrtue of its eligiblllty for appointment as
audltor of a company undèr of sectlon 1212 of the Companies Act 2006.

FRIENDS OF THE CANCER CENTRE
STATEMENT OF FINANCIAL ACTIVITIES
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2024
Unrestricted Restricted
funds
funds
2024
2024
Tolal
Total
2024
2023
Notos
Incomé from:
Donations and legacies
Investments
1,361,754
115,463
200,327
1,562,081
115.463
1,612,179
63,249
Totsl Incom•
1,477,217
200.327 1,677,544
1,675,428
endlturè on:
Charitable activities
1,383,111
219,571
1,602,682 1,627,157
Net gaing1(lossesl on Investments
78.502
78,502
187,390)
Net Incomel(expendlturn) for the yearl
Nel movemant in funds
172,608
(19,2441
153,364
(39,1191
Fund balances at 1 April 2023
3,351,638
46,209 3.397,847 3,436,966
Fund balances at 31 March 2024
3,524,246
26,965 3,551,211
3,397.847
Th8 Statsment of financlal actI￿lIeS Includes all galns and losses recognlsed in the year.
The statement of financial actlvltles Includes all gains and losse8 r8cognised in the year. All Income and expenditure
derive from continuing actlvities.
Thè statement of financl81 actlvities also complles wlth the requirements for an Income and expendlture account
under the Companies Act 2006.
The notes on pages 14 10 24 fom part of these financSal statements,
10-

FRIENDS OF THE CANCER CENTRE
STATEMENT OF FINANCIAL POSITION
ASAT31 MARCH 2024
2024
2023
Notes
Flxod assets
Tangiblé assets
Investments
11
12
1,334
1,214,125
1.594
1,135,623
1,215,459
1,137,217
Current assets
Debtors
Cash at bank and In hand
13
48.992
2,504.936
31.343
2,267,691
2,553,928
2,299,034
Credltor8: amount8 falllng duo wlthln
one yoar
14
{218,1761
{38,404)
Net current assets
2,335,752
2,260,630
Total assets less curront Ilabilltlas
3,551,211
3,397,847
Income funds
Restricted fund5
Unrestricted fund
Designated funds
Gener81 unrestrlcted funds
15
26,965
46,209
16
3,470,503
53,743
3,288,368
63,270
3,524,246
3,351,638
3,551,211
3,397.847
'Please refer to page 3 for further information on unrestricted and deslgnated funds
11

FRIENDS OF THE CANCER CENTRE
STATEMENT OF FINANCIAL POSITION (CONTINUED)
ASAT31 MARCH 2024
Thè company is entitled to thè èxemption from the audlt requirement contained in section 477 of the Companies Act
2006, for the year ended 31 March 2024, although an audit has been carried out under sédlon 65 of the Charltles
Act (Nl) 2008 .
The director acknowledges her rèsponsibilities for ensuring that the charity keeps accounting records whlch comply
with sectlon 386 of the Act and for preparing financlal statements which give a true and fair view of the state of
affairs of the company as al the end of the financial year and of its Incoming resources and application of resources,
including its income and expendllure, for the financial year in accordance with thé requirements of sections 394 and
395 and which othe￿ise comply with the requirements of the Companies Act 2006 relating to financlal statements,
so far as applicable to the company.
Th8 members have nol required the company to obtaln an audit of Its financlal statements under the requirements
of the Compan185 Act 2006, for the year In question In a¢¢ordance wlth section 476.
These financial stat8m8nts have been prepared In accordance wlth the provlsions appllcable to companles sublect
to the small companies regime.
The financlal statements were approved by the Directors on 22 November 2024
FiGh
Donk7
Brian Cave (Nov 21, 2024 13.'39 GMT)
Mr B Cave
Dlr8ctor
Richard Donn3n (Nov 19, 2024 13.'44 GMT)
Mr R Donnan
Dlrector
Company registratlon number N1616925
12-

FRIENDS OF THE CANCER CENTRE
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2024
2024
2023
Notes
Cash flows from operatlng actlvlties
Cash generated froml(absorbed by)
operations
21
122,180
(36,854)
Investlng aclivitie8
Purchase of tangible flxad assèts
Proceeds from disposal of tanglble fixed
assets
Investm8nt Income received
(398)
(1,794)
159
63,249
116,463
Net cash generated from Invostlng
acllvlllg8
115,065
61,614
N•1 cash y￿d In flnanclng actlvltles
Net Incroa8e In cash and cash equlvalonts
237,245
24.760
Cash and cash equivalents at beginnlng of year
2,267,690
2,242,930
Cash and cash equlvalent8 at end of year
2,504,936
2,267,690
13-

FRIENDS OF THE CANCER CENTRE
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
Accountlng pollcies
Charlty informatlon
Friends of the Cancer Centre is a privale company liffllted by guarantee incorporated in Northern Ireland. The
registered office is N.1. Cancer Centre, Belfast City Hospital, Lisbum Road, Belfast, Co. Antrim, BT9 7AB.
1.1 Accounting convention
The financial statements have been prepared in accordance with the Companies Act 2006 and °Accounting
and Reporting by Charities: Statemènt of Recommended Practice applicable to charities preparing their
accounts in accordance wilh the Financial Reporting Standard applicable in the UK and Republic of Ireland
IFRS 102). las amended for accourbting periods commencing from 1 January 2016). The Charity Is a Publlc
Benefit Entity as defined by FRS 102.
The financial statements are prepared in sterling, which is the functional currency of the Charity. Monetary
amounts in these financial statements are rounded to th8 nearest £.
The finan¢i81 statements have been prepared under the historical cost conventlon, modified to include the
revaluation of freehold properties and to include investment propèrtles and certain finandal Instruments at fair
value. The prlnclpal accounting policies adopted are set out below.
1.2 Golng concern
At the lime of approving the financial stat8menls, the Directors have a reasonable expectation that the Charity
has adequate resources to continue in operational existence for the foreseeable future. Thus the Directors
continue to adopt the going concern basis of accounting In preparing the financial statements.
1.3 Charitable funds
Funds hèld by the Charity are eith8r.
Unrestricted general funds these are funds whlch can be used in accordance wlth the charitable
objects at the discretion of the directors.
Designated funds - these are funds Set asld8 by the directors out of unr8Stricted general funds for
specific futur8 purposes or projects.
Restricted funds - these are funds that can only be used for particular restricted purposes within the
objects of the Charity. Restrictions arise when specified by the donor or when the funds are raised
for particular restricled purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financlal
statements.
1.4 Income
Income Is recognised in the period In which the Charlty is entitled to recelpt and the amount can be measured
with reasonable cèrtainty. Income is deferred only when the Charity has to fulfil condltions before becoming
entitled to it or where the donor has specified that the income is to be expended in a future period.
Voluntary income is received by way of donations and gifts and is included in full in the Statement of
Financial Activities (SOFA) when receivable.
Income received from activities for generating funds are included when collecled.
Investment income is included when receivable.
Donated facilities are Included at the value to the Charity where this can be quantified and a third
party Is bearing the cost. No amounts are included in the financial statements for serviGes donatsd
by volunteer5.
14-

FRIENDS OF THE CANCER CENTRE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
Accountlng policies
(Continued
1.5 Expenditura
Expenditure is included in the Statement of Financial Activities (SOFA) on an accruals basls, inclusive of any
VAT which cannot be recovered.
Costs of generaling fvnds comprise the costs associated with attracting voluntary income.
Charitable expenditure comprises those costs incurred by the Charity in the dellvery of its activities
and services for its beneficiaries. It includes both costs that can b6 allocated directly to such activities
and those costs of an indirect nature necessary lo support them.
Governan￿ costs include those costs associated with meeting the constitutional and statutory
requirements of the Charity and include the audit fe8s and costs linked to the strategic management
of the Charity.
All costs are allocated befvéeen the expendlture categorles of the SOFA on a basis designed to reflect
the use of the resource. Costs relatin9 to a particular activity are allocated directly. others are
apportioned on an appropriate basis e.g. staff time and floor space as set out in Note 6.
1.6 Tanglble tlxod assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, nel of
depreciation and any impairment losses.
Depreciation is recognised so as to write off the Cost or valuation of assets less their residual values over their
useful livas on the following bases..
Fixtures and flttings
Computers
15Yo Straight line
250h straight Ilne
The gain or loss arising on the disposal of an asset is determined as the differenc8 between the sale
proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.
1.7 Flxod asset invèslments
Fixed asset investments are initially measur8d at transaction prlce excluding transaction costs, and are
subsequanlly measured at fair valué at each reporting date. Changes in fair value are recognised in net
incomellexpenditurèl for the year. Transaction ¢osts are expensed as Incurred.
1.8 Impalmient of Ilxed assèts
Al each reporting end dale, the CharTty revlews the carrylng amounts of its tangible assets to det8rmlne
whether there is any indication that those assets have suffered an impairment loss. If any such indication
exists, the recoverable amounl of the asset 1$ estlmaled in order to determine the extent of the impaimient
loss (rf any).
1.9 Cash and cash aqulvalents
Cash and cash equivalents include cash in hand. deposits held at call wlth banks. other short-term Ilquld
investments with orlginal maturities of three months or les5. and bank overdrafts. Bank overdrafts are shown
within borrowings in current liabilities.
1.10 Flnancial Instruments
The Charlty has eleded to apply the provi5i0ns of Section 11 'Basic Financial Instruments, and Section 12
'Other Financial Instruments Issues, of FRS 102 to all of its financial instruments.
Financial instruments are recogni5ed in the Charivs balance sheet when the Charily becomes party to the
contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when
there is a legally enforceable right to sel off the recognlsed amounts and there is an intention to settle on a
nel basis or to realise the asset and settle the liability simultaneously.
15-

FRIENDS OF THE CANCER CENTRE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
Accounting pollcle8
(Continued)
Basic financial assots
Basic financial assets, which Indude debtors and cash and bank balances, ar6 Initially measured at
transaction pricè including transaction costs and are subsequently carried at amortised cost using the
effective interest method unlèss the arrangement constitutes a financing transaction, where the transaction is
measured at the present value of the future receipts discounted at a market rate of interest. Financial assèts
classified as receivable within one year are not arnortised.
8aslc flnanclal Ilabllitlos
Basic financial liabilities, including creditors and bank loans a￿ initially recognlsed at transactlon prlce unless
the arrangemenl constitut8s a financing Irans8cts'on, where the debt instrument Is measU￿d at the present
value of the future payments discounted at a market rat8 of interest. Financial liabilities classlfied as payable
within one year are not amortised.
Debt instrum8nts ar8 subsequently ¢arrl8d at amortlsed cost, using the 8ffective interest rate method.
Trade creditors are obligatlons to pay for goods or servlc8s that have been acquired in the ordlnary course of
operations from suppliers. Amounts payable are classified as current liabilities rf payment is due within one
year or less. If not, they are presented as non-current Ilabilities. Trade creditors are recognised inltlally at
transaction price and subsequently maasured at amortised cost uslng the effective interest method.
Derecognltlon of flnanclal Ilabllltles
Financial liabilities are derecognis8d when the Charity's contractual oblsgations expire or are discharged or
cancelled.
Crltlcal accountlng estlmates and Judgements
In the application of the Charlly's accounting pollcles, th8 Directors are required to make judgements,
estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparént
from olher sources. The estimates and associated assumptions arè based on historical experience and other
factors that a￿ consideréd to be relevant. Actual results may differ from thesè estimates.
The estimates and underlying assumptions are revlewed on an ongoing basis. Revisions to accounting
estimates are rècognised in the perlod in which the estimate is revised where the revision affects only that
period. or in the perlod of the revision and fulure periods whére the revision affects both currenl and fulure
periods.
Crftlcal judgement8
Impalrmont and depreclation
Long-lived assets comprising primarily of computer equipment. The annual depreciation charge depends
primarily on the estimated lives of each type of asset and, in certain circumstances, estimates of residual
values. The directors regularly review these useful lives and change them if necessary to reflect current
conditions. In determining these useful lives management consider technological change, patterns of
consumption. physical condition and expeded economic utslisation of the assets. Changes in the useful Ilves
can have a signiflcant impact on the depreciation charge for the financial year. The net book value of tangible
fixed assets subject to depreciation at the financial year end date was £1,334 (2023.. £1,594).
16-

FRIENDS OF THE CANCER CENTRE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
Donations and legaclos
Unrestrictod Restrfcted
funds
funds
Total Unrestrictsd Restrlctsd
fvnds
funds
Total
2024
2024
2024
2023
2023
2023
Donatlons and gifts
Grants
1,361,754
162.127
38,200
1.523,881
38,200
1,390,345
189,631
32.203
1,579,976
32,203
1,361,754
200,327
1,562,081
1.390,345
221,834
1,612,179
Donatlons and glfts
Supporter Events
G8neral Donations
Corporate Donations
Friends Groups
Frlends Events
Legacies
In lieu of flowers
Organisations
HMRC GiftAid
Merchandise
other
325,838
269,785
209,632
23,660
245,198
59,462
110.363
15,875
89.518
6,432
5,991
325,838
269,835
278,344
25.700
250,298
59,462
110,987
15,875
90,119
6,432
90,991
360,537
236,870
153.674
12,173
307,135
98.023
129,225
11,635
70,974
4,741
5,358
1,000
4,514
56,190
361,537
241,384
209,864
12.173
309,578
98,023
131,340
63,935
72,043
4,741
75,358
50
68,712
2,040
5,100
2,443
624
2,115
52,3CNJ
1,069
601
85,000
70,000
1,361,754
162,127
1,523,881
1,390,345
189,631
1.579,976
Other Income Includes £4,000 (2023.. £4,000) ol donated s8rvI￿S and facilities which comprise the provislon
of office space and administration services. A corresponding amount is included wlthln the cost of charitable
activitles.
Grants rècèlvablo for
coro actlvltles
Community Foundation
Nl
Dormant Account Fund
6,000
6,000
32,200
32,200
32,203
32,203
38,200
38,200
32,203
32.203
17-

FRIENDS OF THE CANCER CENTRE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
Income from Investments
Unrnstrlcted Unrestricted
funds
funds
2024
2023
Investment income
115,463
63,249
Charltabla actlvltles
2024
2023
Research projects
Patient ￿rnfort
Patlent care
Project support
FurKlraislng
Administratlon
Campaigns
423,471
309,899
407,651
220,377
127,384
66,374
24,184
397,155
318,261
388,710
229,762
162,349
76,461
32.388
1.579,340 1,605,084
Share of support costs (see note 6)
Share of governance Costs (see note 6)
19,842
3,500
18,573
3,500
1,602,682 1,627,157
Analysls by fund
Unrestricted funds
Restricted funds
1,383,111
219,571
1,373,885
253.272
1,602,682 1,627,157
18-

FRIENDS OF THE CANCER CENTRE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
Support costs
Support Govemance
costs
2024
Support Governanco
costs
costs
2023
Insuran
Rent, electrlcity gnd
telephone
Fundraiserfs expenses
Bank fees
Legal and profession81
expenses
Depreciation
2.555
2,555
2,847
2,847
4,000
7.885
2,010
4,000
7,885
2.010
4,000
6,293
1,938
4,000
6,293
1.938
2,733
658
2,733
658
2,294
1,201
2,294
1,201
Gov8rnanc8 Costs
3,500
3,500
3,500
3.500
19.841
3.500
23.341
18,573
3,500
22,073
Analysed be￿een
Charitable activities
19,842
3,500
23,342
18,573
3,500
22,073
Dlrectors
None of the Directors lor 8ny persons connected wlth them) received any remuneration or benefits from the
Charity during the year.
Employees
The average monthly number of employeès during the year was..
2024
Number
2023
Numbor
Admlnlstratlon
Directors
15
12
Total
24
21
Employmont costs
2024
2023
Wages and salaries
Social securily costs
Other pension costs
296,337
21,365
22,610
307,765
27,936
25,309
340,312
361.010
19-

FRIENDS OF THE CANCER CENTRE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
Employees
(Contlnued)
There was no employee wlth emoluments in excess of £60,000 per annum (2023.. 1).
The totsl amount of employee benefits recelved by key management personnel in the period was £164,211
12023: £219,772). The key management personnel of the Company comprises 3 members of staff (2023.. 4).
the CEO, Finance & Admlnlslration Manager and the Communications & Projecl Manager.
Net galn81(losses) on Investmènts
Unrèstrlct
funds
Total
2024
2023
R8valuation of investm8nts
78,502
(87,390)
10 Taxatlon
The charity is exempt from taxation on its actlvltles because all its incom8 is applied for charitable purposes.
11 Tanglble flX￿ assets
FlxtuTM und Comput•r•
flttlngs
Total
Cost
At 1 Aprfl 2023
Addllions
1,572
14,175
398
15,747
398
At 31 Ma￿h 2024
1,572
14,573
16,145
Depreclatlon and Impalrment
Al 1 April 2023
Depreciation charged in the year
1,572
12,581
658
14,153
658
At 31 March 2024
1,572
13,239
14,811
Carrylng amount
At 31 March 2024
1.334
1,334
At 31 March 2023
1,594
1,594
-20-

FRIENDS OF THE CANCER CENTRE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
12 Flxed asset investments
Llsted
Invèstments
Cost or valuatlon
At 1 April 2023
Valuation changes
1,135,623
78,502
At 31 March 2024
1.214.125
Carrylng amount
At 31 Mar¢h 2024
1,214.125
At 31 March 2023
1,135,623
The Investments ar8 held as part of the North8m Ireland Central Investment fund for Charities. The
Investments are held at Market Value.
13 Debtors
2024
2023
Amounts falllng duo wlthln ono yaar.
Other debtors
Prepayments and accrued Income
46,243
2,749
28,474
2,870
48,992
31,344
14 Credttor8: amounts falllng duo wlthln one year
2024
2023
Other creditors
Accruals and deferred income
166.205
51,971
20.424
17.980
218.176
38,404
21

FRIENDS OF THE CANCER CENTRE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
15 Restrictad funds
The restrictéd funds of the charlty comprise the unexpended balances of donatlons and grants held on trust subject to
specific conditions by donors as to how thèy may be used.
Movemènt In funds
Incomlng
Resour¢•s
Balance at
r•sour¢o5
•xponded 31 March 2024
Balance at
1 Aprll 2023
Research
Patient Care
Patient Comfort
Grants recelved
20,871
127.982
13,274
38,200
120,871)
{133,9171
113,274)
(51,5091
10.357
11,875
23,977
4.422
11,875
10,668
46,209
200,327
1219,5711
26,965
RestrlGted funds are legacie5 and donations received for sp8cifi8d purposes withln the overall aims of the Charity.
Funds recelved for research are used to support cancer research in the centre.
Induded withln Clinical care is £48,442 received from Applegreen Plc. This partnèrship works to provide support for the
Centre's Teenager and Young Adult Programm8, funding vital nursing hours for teenagers and young adults with support
durlng and after treatment.
-22-

FRIENDS OF THE CANCER CENTRE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
16 Da8ignated funds
The unrestricted funds of the charity compris8 the unexpended balances of donations and grants which arè
not subject lo specific condltlons by donors and grantors as to how they may be usèd. These include
designated funds which have been set asid8 Out of unrestricted funds by the trustees for specific purposes.
Balance at
1 Aprll 2023
Ré8ourc•$
èxpended
Transfern
Balance at
31 March 2024
Research
Patient Care
Patlent Comfort
Campalgns
791,296
1,958,666
538,404
1423.470)
1309,900)
1407,651)
124,184)
101,207
784,427
397,525
64,184
469,033
2.433,193
528.278
40,000
3,288,366 {1,165,2051 1,347,342
3,470,503
Many of the projects funded by the Charity span several years. For example, a research project post may be
approved for more than one year or, th8 purchase of equipment may requlre a maintenancé contract. To
recognlse Ihese future commitments and ensure that there are unexpected interruptions In the funding of
the work supported by the Charity, the directors designate the funds needed for the next year of the project.
For some specific prolects two years of required funds have been designated. Designated funds are not
restricted by nature.
17 Analysls of not assets botween funds
Unrestrlcted Restrlcted
funds
funds
2024
2024
Total Unrestrlcted Restrictèd
funds
funds
2023
2023
Total
2024
2023
Fund balances 8131
March 2024 are
represented by..
Tangible assets
Investrnenls
Current assetsl{liabilities)
1,334
1,214,125
2,308,787
1,334
1,594
1,214.125 1,135,623
26.965 2.335,752 2,223,013
1,594
1,135,623
37,615 2,260.628
3,524,246
26,965
3,551,211 3,360.230
37,615 3,397,845
18 Rellrement bonoflt schemes
Defined contrlbution Schemes
The Charity operates a defined contrlbution pension scheme for all qualifying employees. The assets of the
scheme are held separately from those of thè Charity in an independently administered fund. The pension
cost and charge represents contributions payable by the company to the fund and amounts to £22,610 (2023:
25,309).
19 Financlal commitments, guarantees and contingent liabilttles
There were no financial commitments at the balance sheet date over and above monies in designated funds.
-23-

FRIENDS OF THE CANCER CENTRE
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
20 Related party transactlons
There were no di5closable related paty transactions during the year {2023 - none).
21 Cash generated from operatlons
2024
2023
Surplusl(deficit) for the year
153,364
139,119)
Adjustments for..
Investment income recogn15ed in statement of linancial activities
(Gain}Iloss on disposal of investments
Depreciation and impairment of tangible fixed assets
1115,463)
(78,502)
658
163.249)
87,390
1,200
Movements in working capital..
Ilncreasel in debtors
In¢r8aselldecr8asel in creditors
117,6491
179.772
(9,5941
113.482)
Cash generat•d froml(absorbed by) operatlons
122,180
136,854)
-24-